Valbenazine

BreastfeedingPediatric

FDA APPROVAL DATE: 04/11/2017

CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Carbamazepine, Clarithromycin, Digoxin, Fluoxetine, Isocarboxazid, Itraconazole, Ketoconazole, MAO inhibitors, Paroxetine Hydrochloride, Phenelzine, Phenytoin, Quinidine, Rifampin, Selegiline, St John's Wort, Strong CYP2D6 inducers, Strong CYP3A4 inducers or inhibitors

PREGNANCY CATEGORY: N/A
May cause fetal harm

Our database has 35 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

MUCOSAL
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
GENITOURINARY
OCULAR


Page last updated 05/10/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric